ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
Javier PascualMedical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Malaga, SpainGerhardt AttardUrological Cancer Research, University College London, London, UKFrançois‐Clément BidardDepartment of Medical Oncology, Institut Curie, Paris, France; University of Versailles Saint-Quentin-en-Yvelines (UVSQ)/Paris-Saclay University, Saint Cloud, FranceGiuseppe CuriglianoDepartment of Oncology and Hemato-Oncology, University of Milano, Milan, Italy; Division of Early Drug Development, European Institute of Oncology, IRCCS, Milan, ItalyLeticia De Mattos‐ArrudaIrsiCaixa, Hospital Universitari Trias i Pujol, Badalona, Spain; Germans Trias i Pujol Research Institute (IGTP), Badalona, SpainMaximilian DiehnDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, USAAntoîne ItalianoEarly Phase Trials and Sarcoma Units, Institut Bergonie, Bordeaux, France; DITEP, Gustave Roussy, Villejuif, France; Faculty of Medicine, University of Bordeaux, Bordeaux, FranceJohan LindbergDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, SwedenJason D. MerkerDepartments of Pathology and Laboratory Medicine & Genetics, UNC School of Medicine, Chapel Hill, USAClara MontagutMedical Oncology Department, Hospital del Mar-IMIM, CIBERONC, Universitat Pompeu Fabra, Barcelona, SpainNicola NormannoCell Biology and Biotherapy Unit, Istituto Nazionale Tumori, 'Fondazione G. Pascale' - IRCCS, Naples, ItalyKlaus PantelInstitute for Tumour Biology, University Medical Centre Hamburg-Eppendorf, Hamburg, GermanyGeorge PentheroudakisScientific and Medical Division, European Society for Medical Oncology, Lugano, SwitzerlandSanjay PopatRoyal Marsden Hospital, London, UK; Institute of Cancer Research, London, UKJorge S. Reis‐FilhoDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, USAJeanne TieDepartment of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Division of Personalised Oncology, Walter and Eliza Hall Institute of Medical Research, Melbourne, AustraliaJoan SeoanePreclinical and Translational Research Programme, Vall d'Hebron Institute of Oncology (VHIO), ICREA, CIBERONC, Barcelona, Spain; Medical School, Universitat Autònoma de Barcelona, Barcelona, SpainN. TarazonaDepartment of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Instituto de Salud Carlos III, CIBERONC, Madrid, SpainTakayuki YoshinoDepartment of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, JapanNicholas C. TurnerRoyal Marsden Hospital, London, UK; Institute of Cancer Research, London, UK. Electronic address: [email protected]
2022en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0